Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · Real-Time Price · USD
5.74
+0.58 (11.24%)
Dec 20, 2024, 4:00 PM EST - Market closed
Verve Therapeutics Market Cap
Verve Therapeutics has a market cap or net worth of $485.97 million as of December 20, 2024. Its market cap has decreased by -53.19% in one year.
Market Cap
485.97M
Enterprise Value
17.31M
1-Year Change
-53.19%
Ranking
Category
Stock Price
$5.74
Market Cap Chart
Since the IPO on June 17, 2021, Verve Therapeutics's market cap has decreased from $869.34M to $485.97M, a decrease of -44.10%. That is a compound annual growth rate of -15.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 485.97M | -56.65% |
| Dec 29, 2023 | 1.12B | -5.95% |
| Dec 30, 2022 | 1.19B | -32.88% |
| Dec 31, 2021 | 1.78B | 104.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Auna S.A. | 501.16M |
| EyePoint Pharmaceuticals | 498.14M |
| Terns Pharmaceuticals | 497.74M |
| Cartesian Therapeutics | 489.30M |
| Third Harmonic Bio | 488.43M |
| MeiraGTx Holdings | 480.64M |
| PureTech Health | 480.54M |
| Alumis | 479.87M |